265 related articles for article (PubMed ID: 32463685)
1. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
[TBL] [Abstract][Full Text] [Related]
2. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
3. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
[TBL] [Abstract][Full Text] [Related]
4. Choosing Appropriate Solvents for ASD Preparation.
Luebbert C; Real D; Sadowski G
Mol Pharm; 2018 Nov; 15(11):5397-5409. PubMed ID: 30335401
[TBL] [Abstract][Full Text] [Related]
5. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
[TBL] [Abstract][Full Text] [Related]
6. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
7. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
[TBL] [Abstract][Full Text] [Related]
8. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
Veith H; Wiechert F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
[TBL] [Abstract][Full Text] [Related]
9. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
10. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
11. Predicting process design spaces for spray drying amorphous solid dispersions.
Dohrn S; Rawal P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm X; 2021 Dec; 3():100072. PubMed ID: 33855291
[TBL] [Abstract][Full Text] [Related]
12. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
[TBL] [Abstract][Full Text] [Related]
13. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.
Paudel A; Van den Mooter G
Pharm Res; 2012 Jan; 29(1):251-70. PubMed ID: 21773852
[TBL] [Abstract][Full Text] [Related]
14. Phase Behavior of Drug-Hydroxypropyl Methylcellulose Amorphous Solid Dispersions Produced from Various Solvent Systems: Mechanistic Understanding of the Role of Polymer using Experimental and Theoretical Methods.
Mugheirbi NA; Mosquera-Giraldo LI; Borca CH; Slipchenko LV; Taylor LS
Mol Pharm; 2018 Aug; 15(8):3236-3251. PubMed ID: 29874454
[TBL] [Abstract][Full Text] [Related]
15. Chemically identical but physically different: A comparison of spray drying, hot melt extrusion and cryo-milling for the formulation of high drug loaded amorphous solid dispersions of naproxen.
Dedroog S; Huygens C; Van den Mooter G
Eur J Pharm Biopharm; 2019 Feb; 135():1-12. PubMed ID: 30529295
[TBL] [Abstract][Full Text] [Related]
16. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
17. Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying.
Smeets A; Koekoekx R; Clasen C; Van den Mooter G
Eur J Pharm Biopharm; 2018 Sep; 130():96-107. PubMed ID: 29928980
[TBL] [Abstract][Full Text] [Related]
18. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
19. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Amorphous Solid Dispersions of Spironolactone Prepared by Spray Drying and Electrospinning: The Influence of the Preparation Method on the Dissolution Properties.
Szabó E; Záhonyi P; Brecska D; Galata DL; Mészáros LA; Madarász L; Csorba K; Vass P; Hirsch E; Szafraniec-Szczęsny J; Csontos I; Farkas A; Van denMooter G; Nagy ZK; Marosi G
Mol Pharm; 2021 Jan; 18(1):317-327. PubMed ID: 33301326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
